Does ADALIMUMAB Cause Hepatic cancer? 193 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 193 reports of Hepatic cancer have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.0% of all adverse event reports for ADALIMUMAB.
193
Reports of Hepatic cancer with ADALIMUMAB
0.0%
of all ADALIMUMAB reports
62
Deaths
78
Hospitalizations
How Dangerous Is Hepatic cancer From ADALIMUMAB?
Of the 193 reports, 62 (32.1%) resulted in death, 78 (40.4%) required hospitalization, and 10 (5.2%) were considered life-threatening.
Is Hepatic cancer Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 193 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Hepatic cancer?
RANITIDINE (17,818)
SORAFENIB (228)
LEDIPASVIR\SOFOSBUVIR (197)
RIBAVIRIN (190)
VALSARTAN (165)
RIFAXIMIN (151)
SOFOSBUVIR (141)
ETANERCEPT (97)
ENTECAVIR (94)
APIXABAN (93)
Which ADALIMUMAB Alternatives Have Lower Hepatic cancer Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB